All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Construction and large-scale production of recombinant proteins, derived from Epstaein-Barr virus nuclear antigen 1 (EBNA 1), and their application to the diagnostics of infectious diseasea.

Public support

  • Provider

    Ministry of Industry and Trade

  • Programme

    TANDEM

  • Call for proposals

    TANDEM 2 (SMPO200500008)

  • Main participants

  • Contest type

    VS - Public tender

  • Contract ID

    FT-TA2/015

Alternative language

  • Project name in Czech

    Vývoj a příprava rekombinantních proteinů odvozených z antigenní struktury proteinu EBNA1 viru Epsteina a Barrové a jejich využití pro diagnostiku infekčních onemocnění.

  • Annotation in Czech

    Cílem projektu je vyvinout a diagnosticky ověřit rekombinantní proteiny, obsahující pouze virově specifické antigenní determinanty EBNA 1, a s jejich pomocí zkonstruovat diagnostickou soupravu na stanovení lidských protilátek proti tomuto proteinu.

Scientific branches

  • R&D category

    VV - Exeperimental development

  • CEP classification - main branch

    FN - Epidemiology, infection diseases and clinical immunology

  • CEP - secondary branch

    EB - Genetics and molecular biology

  • CEP - another secondary branch

  • OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    10603 - Genetics and heredity (medical genetics to be 3)<br>10604 - Reproductive biology (medical aspects to be 3)<br>10605 - Developmental biology<br>10608 - Biochemistry and molecular biology<br>10609 - Biochemical research methods<br>30101 - Human genetics<br>30302 - Epidemiology<br>30303 - Infectious Diseases

Completed project evaluation

  • Provider evaluation

    U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

  • Project results evaluation

    The recombinant EBNA-1 antigens were prepared and technology of their production, isolation and purification was developed. The high sensitive diagnostic ELISA kit with better diagnostic availability was prepared.

Solution timeline

  • Realization period - beginning

    Aug 1, 2005

  • Realization period - end

    Jul 31, 2007

  • Project status

    U - Finished project

  • Latest support payment

    Mar 23, 2007

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP08-MPO-FT-U/01:1

  • Data delivery date

    Jun 20, 2008

Finance

  • Total approved costs

    4,344 thou. CZK

  • Public financial support

    1,616 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    2,727 thou. CZK